Aktie A2PAUC MILLENDO THERAPEUTICS
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Millendo Therapeutics

Aktien

A2PAUC

US60040X1037

MLND

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Millendo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Millendo Therapeutics, Inc. and Tempest Therapeutics, Inc. Enter into First Amendment to Loan and Security Agreement
Millendo Therapeutics, Inc. Joins Nicholas Maestas as Vice President, Strategy and Finance and It's Principal Financial Officer
TEMPEST THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Tempest Therapeutics : BUSINESS (Form 8-K)
TEMPEST THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Tempest Therapeutics : to Participate in William Blair 2021 Biotech Focus Conference
TEMPEST THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
Tempest Therapeutics : to Participate in William Blair 2021 Biotech Focus Conference
TEMPEST THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Millendo Therapeutics : Amendment to Current Report (SEC Filing - 8-K/A)
Tempest Therapeutics : MILLENDO THERAPEUTICS, INC. Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K/A)
Millendo Therapeutics : Tempest Closes Merger with Millendo and Completes PIPE Financing (Form 8-K)
Millendo Therapeutics, Inc.(NasdaqCM:MLND) dropped from NASDAQ Composite Index
Tempest Therapeutics Inc. completed the acquisition of Millendo Therapeutics, Inc. in a reverse merger transaction for approximately $180 million.
Millendo Therapeutics : Tempest and Millendo Announce Stockholder Approval of Merger (Form 8-K)
MILLENDO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
Millendo Therapeutics : , Tempest Therapeutics Investors Approve Merger Proposals
MILLENDO THERAPEUTICS, INC. : Other Events (form 8-K)
MILLENDO THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PAUC Aktie
  4. Nachrichten Millendo Therapeutics
  5. Andere Sprachen